Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors

Papotti, Mauro, Duregon, Eleonora, Volante, Marco and McNicol, Anne Marie (2014) Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors. Endocrine Pathology, 25 1: 35-48. doi:10.1007/s12022-013-9291-6


Author Papotti, Mauro
Duregon, Eleonora
Volante, Marco
McNicol, Anne Marie
Title Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors
Journal name Endocrine Pathology   Check publisher's open access policy
ISSN 1046-3976
1559-0097
Publication date 2014-03
Year available 2014
Sub-type Article (original research)
DOI 10.1007/s12022-013-9291-6
Open Access Status
Volume 25
Issue 1
Start page 35
End page 48
Total pages 14
Place of publication Totowa, NJ, United States
Publisher Humana Press
Collection year 2015
Language eng
Formatted abstract
A reappraisal of the major advances in the diagnostic pathology of adrenal cortical lesions and tumors in the last 25 years is presented, with special reference to the definition of malignancy in primary adrenal cancer and its variants. Slightly more than 25 years ago, Weiss proposed his diagnostic scoring system for adrenal cortical carcinoma. This represented a milestone for adrenal pathologists and the starting point for further modifications of the system, either through minor changes in the scoring procedure itself or concentrating on some particular Weiss criterion such as mitotic index, integrated into alternative scoring schemes or algorithms that are currently under validation. Improvements in diagnostic immunohistochemistry have led to the identification of markers of cortical origin, such as Melan-A, alpha-inhibin, and SF-1 and of prognostic factors in carcinoma, such as the Ki-67 proliferation index and SF-1 itself. With regard to hyperplastic conditions, genetic investigations have allowed the association of the majority of cases of primary pigmented nodular adrenocortical disease (PPNAD) in Carney complex to mutations in the gene encoding the regulatory subunit 1A of protein kinase A (PRKAR1A). Other hereditary conditions are also associated with adrenal cortical tumors, including the Li–Fraumeni, Beckwith–Wiedemann, Gardner, multiple endocrine neoplasia type 1, and neurofibromatosis type 1 syndromes. Moreover, several advances have been made in the knowledge of the molecular background of sporadic tumors, and a number of molecules/genes are of particular interest as potential diagnostic and prognostic biomarkers.
Keyword Adrenal cortex
Pathology
Adenoma
Carcinoma
Diagnostic criteria
Update
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: UQ Centre for Clinical Research Publications
Official 2015 Collection
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 12 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 14 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 18 May 2014, 00:05:07 EST by System User on behalf of UQ Centre for Clinical Research